10/26/2021
https://congress.gov...
"We are going to move forward with them."
"Both you and the FDA Commissioner Hamburg gave assurances to the generic industry that the Biosimilar User Fee Program would receive 20 million in funding."
"the imbalance of inspection requirements between U.S. and foreign manufacturing facilities creates an uneven playing field for pharmaceutical plants in the U.S."
"Thank you, Chairman Pitts."